Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PTNS + Mirabegron for Refractory OAB
NCT04907032Phase 4Completed
- Sponsor
- University of Alabama at Birmingham
- Start
- Oct 2021
- Primary completion
- Apr 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of mirabegron in urge incontinence, overactive bladder (OAB), sponsored by University of Alabama at Birmingham. Started Oct 2021; status: completed.
02
Drugs
mirabegron
03
Conditions
urge incontinenceoveractive bladder (OAB)
Beyond the preview
Go deeper on NCT04907032.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04907032.